Skip to content

The effect of low dose intravenouse ketamine on post operative pain after cesarean section with spinal anesthesia

The effect of low dose intravenouse ketamine on post operative pain after cesarean section with spinal anesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012100611019N1
Enrollment
160
Registered
2013-07-09
Start date
2012-12-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain. Generalized pain NOS

Interventions

Intervention 1: All patients received spinal anesthesia (BUPIVACAINE 7-12 mg intrathecally by needle No: 25 at L3-L4 space). Patients were randomly divided into two groups. First group receives Ketami
Treatment - Drugs
Placebo
All patients received spinal anesthesia (BUPIVACAINE 7-12 mg intrathecally by needle No: 25 at L3-L4 space). Patients were randomly divided into two groups. First group receives Ketamin 0.25 mg/kg int
After spinal anesthesia as the first group, control group receives salin normal as placebo intrathecally 5 minutes after section. The first time of pain complaint after cesarean section and request fo

Sponsors

Semnan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Inclusion criteria included: Singleton pregnancy, semester, elective cesarean section; perform cesarean sections by Fan slices Ashtyl; not having a history of drug abuse; no history of chronic diseases such as diabetes; surgery with spinal anesthesia; no previous surgery;a level of intelligence cooperation; class ASA 1, 2 Exclusion criteria:excessive bleeding during and after surgery; Sensitivity to ketamine; psychological problems (psychotic disorder); contraindication for spinal anesthesia; Hypertension; High Icp; a history of seizures; history of ketamine use and hallucination after that.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Analgesia. Timepoint: ?In the first day of study. Method of measurement: Pain Score.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehri Leysi

Semnan University of Medical Sciences

mehrileysi @yahoo.com+98 23 1446 3052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026